We are live on ! Find out more
ATEX icon

Anterix

100 hedge funds and large institutions have $567M invested in Anterix in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 49 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

14,271% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $7K

113% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 23

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

13% more funds holding in top 10

Funds holding in top 10: 89 (+1)

6% more funds holding

Funds holding: 94100 (+6)

3.99% more ownership

Funds ownership: 79.62%83.62% (+4%)

9% less capital invested

Capital invested by funds: $621M → $567M (-$53.4M)

Holders
100
Holders Change
+6
Holders Change %
+6.38%
% of All Funds
1.72%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.16%
New
16
Increased
49
Reduced
23
Closed
9
Calls
$1.01M
Puts
$7K
Net Calls
+$999K
Net Calls Change
-$1.48M

ATEX Hedge Fund Activity: Q3 2022 in Review

100 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Anterix (ATEX) for Q3 2022, worth a combined $567M — down 8.6% from $621M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ATEX positions and 9 closed out — a net gain of 7 holders — while 49 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $12.7M. The largest seller was Jennifer C. Price, cutting an estimated $5.03M.

  • 100 institutional investors held Anterix (ATEX) as of Q3 2022, up from 94 in Q2 2022.
  • Funds reported $567M of Anterix stock for Q3 2022, down 8.6% quarter-over-quarter.
  • 16 funds opened new Anterix positions in Q3 2022 and 9 closed out, a net change of +7 holders.
  • The largest Anterix buyer in Q3 2022 was BlackRock, an estimated $12.7M added.
  • The largest Anterix seller in Q3 2022 was Jennifer C. Price, an estimated $5.03M sold.

Based on aggregated 13F filings for Q3 2022.